PERCLOT POLYSACCHARIDE HEMOSTATIC SYSTEM
PerClot Polysaccharide Hemostatic System (PHS) is indicated for use in surgical procedures (except neurological and ophthalmic) or injuries as an adjunct hemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical.
PERCLOT POLYSACCHARIDE HEMOSTATIC SYSTEM
Industry:
Biotechnology Clinical Trials Health Care
Address:
Deerfield, Illinois, United States
Country:
United States
Status:
Active
Similar Organizations
BIND Therapeutics
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
CardioCell
CardioCell is currently in clinical trials using stem cells to develop highly effective, “off-the-shelf” therapeutic products.
PRA International
PRA International is one of the world's leading global clinical research organizations, conducting clinical trials in more than 85